chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination complication, Vision blurred
Clinical narrative: it seems like it is getting worse; today i had numbness (in her eyes); blurring in my eyes; leg is sore and stuff; had a reaction to the vaccine; weakness in the left leg; leg has been swollen; really bad headaches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (had a reaction to the vaccine), MUSCULAR WEAKNESS (weakness in the left leg), PERIPHERAL SWELLING (leg has been swollen), HYPOAESTHESIA EYE (today i had numbness (in her eyes)) and VISION BLURRED (blurring in my eyes) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O3OA21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history was not reported.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced VACCINATION COMPLICATION (had a reaction to the vaccine), MUSCULAR WEAKNESS (weakness in the left leg), PERIPHERAL SWELLING (leg has been swollen), PAIN IN EXTREMITY (leg is sore and stuff) and HEADACHE (really bad headaches). On 02-Apr-2021, the patient experienced HYPOAESTHESIA EYE (today i had numbness (in her eyes)) and VISION BLURRED (blurring in my eyes). On an unknown date, the patient experienced CONDITION AGGRAVATED (it seems like it is getting worse). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at a dose of 1 UNK. At the time of the report, VACCINATION COMPLICATION (had a reaction to the vaccine), MUSCULAR WEAKNESS (weakness in the left leg), PERIPHERAL SWELLING (leg has been swollen), HYPOAESTHESIA EYE (today i had numbness (in her eyes)), VISION BLURRED (blurring in my eyes), PAIN IN EXTREMITY (leg is sore and stuff), CONDITION AGGRAVATED (it seems like it is getting worse) and HEADACHE (really bad headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported include high blood pressure medication,high cholesterol medication.   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Reporter Contact information updated.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore arm at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm at the site of injection) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concomitant products included PARACETAMOL (TYLENOL) for Ache.   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 25-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore arm at the site of injection). At the time of the report, VACCINATION SITE PAIN (Sore arm at the site of injection) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   The concomitant medications were not provided.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pallor, Vascular occlusion
Clinical narrative: Vascular occlusion; Blanching of skin; Bruising; This spontaneous case was reported by a nurse and describes the occurrence of CONTUSION (Bruising) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Gastric bypass. Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included BOTULINUM TOXIN TYPE A HAEMAGGLUTININ COMPLEX (DYSPORT), HYALURONIC ACID (RESTYLANE), DURAPATITE (RADIESSE), LIDOCAINE and VORHYALURONIDASE ALFA (HYLENEX) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced CONTUSION (Bruising). The patient was treated with MULTIVITAMINS [VITAMINS NOS] at an unspecified dose and frequency. At the time of the report, CONTUSION (Bruising) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient had history of fillers or toxins.   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Non significant follow up received on 17-MAY-2021, no new information On 16-Jul-2021: reporter provided causality
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: Vaccine administered after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered after temperature excursion) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered after temperature excursion). On 02-Apr-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered after temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that there was a power outage on 02-Apr-2021 and vials were in freezer and refrigerator where temperature dropped to -13.79 C  in freezer for 47 minutes and to 12 C in refrigerator for 59 minutes.  No concomitant products were reported.  No treatment information was provided.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Myalgia, Swelling, Tenderness, Vaccination site pain
Clinical narrative: Aches; sore arm from the injection site; swelling underneath the armpit of her right arm, size of "cutie oranges",; swelling from underneath the armpit is tender; swelling in the right arm , where the vaccine was administered; pain in the right arm , where the vaccine was administered; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Apr-2021 and was forwarded to Moderna on 05-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in the right arm , where the vaccine was administered), SWELLING (swelling underneath the armpit of her right arm, size of "cutie oranges",), TENDERNESS (swelling from underneath the armpit is tender), VACCINATION SITE SWELLING (swelling in the right arm , where the vaccine was administered) and MYALGIA (Aches) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE PAIN (pain in the right arm , where the vaccine was administered) and VACCINATION SITE SWELLING (swelling in the right arm , where the vaccine was administered). On 03-Apr-2021, the patient experienced SWELLING (swelling underneath the armpit of her right arm, size of "cutie oranges",) and TENDERNESS (swelling from underneath the armpit is tender). On an unknown date, the patient experienced MYALGIA (Aches) and INJECTION SITE PAIN (sore arm from the injection site). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and ACETAMINOPHEN at a dose of 1 dosage form. At the time of the report, VACCINATION SITE PAIN (pain in the right arm , where the vaccine was administered), SWELLING (swelling underneath the armpit of her right arm, size of "cutie oranges",), TENDERNESS (swelling from underneath the armpit is tender), VACCINATION SITE SWELLING (swelling in the right arm , where the vaccine was administered), MYALGIA (Aches) and INJECTION SITE PAIN (sore arm from the injection site) outcome was unknown.            No concomitant medication information was mentioned  Patient took acetaminophen q4-6hrs on Saturday for treatment.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the event was not applicable
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Aches; sore arm from the injection site; swelling underneath the armpit of her right arm, size of "cutie oranges",; swelling from underneath the armpit is tender; swelling in the right arm , where the vaccine was administered; pain in the right arm , where the vaccine was administered; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Apr-2021 and was forwarded to Moderna on 05-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in the right arm , where the vaccine was administered), SWELLING (swelling underneath the armpit of her right arm, size of "cutie oranges",), TENDERNESS (swelling from underneath the armpit is tender), VACCINATION SITE SWELLING (swelling in the right arm , where the vaccine was administered) and MYALGIA (Aches) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE PAIN (pain in the right arm , where the vaccine was administered) and VACCINATION SITE SWELLING (swelling in the right arm , where the vaccine was administered). On 03-Apr-2021, the patient experienced SWELLING (swelling underneath the armpit of her right arm, size of "cutie oranges",) and TENDERNESS (swelling from underneath the armpit is tender). On an unknown date, the patient experienced MYALGIA (Aches) and INJECTION SITE PAIN (sore arm from the injection site). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and ACETAMINOPHEN at a dose of 1 dosage form. At the time of the report, VACCINATION SITE PAIN (pain in the right arm , where the vaccine was administered), SWELLING (swelling underneath the armpit of her right arm, size of "cutie oranges",), TENDERNESS (swelling from underneath the armpit is tender), VACCINATION SITE SWELLING (swelling in the right arm , where the vaccine was administered), MYALGIA (Aches) and INJECTION SITE PAIN (sore arm from the injection site) outcome was unknown.            No concomitant medication information was mentioned  Patient took acetaminophen q4-6hrs on Saturday for treatment.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the event was not applicable
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: after the second got it has gotten extremely worse. It is worse than my pain, and it has radiated to her hand and fingers; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (after the second got it has gotten extremely worse. It is worse than my pain, and it has radiated to her hand and fingers) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001B21A and 031M20A) for COVID-19 vaccination.     No medical history was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (after the second got it has gotten extremely worse. It is worse than my pain, and it has radiated to her hand and fingers). The patient was treated with IBUPROFEN at a dose of 1 dosage form and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN (after the second got it has gotten extremely worse. It is worse than my pain, and it has radiated to her hand and fingers) had not resolved.            Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided.    This case was linked to MOD21-066386 (E2B Linked Report). This case was linked to MOD-2021-064167 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: follow up received  on 24-may 2021 no significant information received.; Sender's Comments:  MOD21-066386:Husband's case
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Broke out in hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Broke out in hives) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included Hives. Concomitant products included CAMPHOR, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC OXIDE (BENADRYL [CAMPHOR;DIPHENHYDRAMINE HYDROCHLORIDE;ZINC OXIDE]), CALCIUM, MAGNESIUM, VITAMIN D NOS, METOPROLOL and LEVOTHYROXINE for an unknown indication.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced URTICARIA (Broke out in hives). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, URTICARIA (Broke out in hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Upon internal review on 09-Aug-21, the age was corrected to 84 years.   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow-up information received on 07-Jul-2021 contains non-significant information.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain lower, Anxiety, Chest pain, Depression, Ear pain
Clinical narrative: pain behind ear; burning of her chest (like a sunburn); colder skin; tearful; anxiety; more depressed than usual; Pain in lower abdomen periodically; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (pain behind ear), CHEST PAIN (burning of her chest (like a sunburn)), PERIPHERAL COLDNESS (colder skin), TEARFULNESS (tearful) and ANXIETY (anxiety) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EAR PAIN (pain behind ear), CHEST PAIN (burning of her chest (like a sunburn)), PERIPHERAL COLDNESS (colder skin), TEARFULNESS (tearful), ANXIETY (anxiety), DEPRESSION (more depressed than usual) and ABDOMINAL PAIN LOWER (Pain in lower abdomen periodically). At the time of the report, EAR PAIN (pain behind ear), CHEST PAIN (burning of her chest (like a sunburn)), PERIPHERAL COLDNESS (colder skin), TEARFULNESS (tearful), ANXIETY (anxiety), DEPRESSION (more depressed than usual) and ABDOMINAL PAIN LOWER (Pain in lower abdomen periodically) outcome was unknown.            No concomitant medication were provided.  No treatment medication were provided.  Action taken in response to mRNA-1273 was considered to be not applicable.   This case was linked to MOD-2021-058166 (Patient Link).
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral coldness, Tearfulness
Clinical narrative: pain behind ear; burning of her chest (like a sunburn); colder skin; tearful; anxiety; more depressed than usual; Pain in lower abdomen periodically; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (pain behind ear), CHEST PAIN (burning of her chest (like a sunburn)), PERIPHERAL COLDNESS (colder skin), TEARFULNESS (tearful) and ANXIETY (anxiety) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EAR PAIN (pain behind ear), CHEST PAIN (burning of her chest (like a sunburn)), PERIPHERAL COLDNESS (colder skin), TEARFULNESS (tearful), ANXIETY (anxiety), DEPRESSION (more depressed than usual) and ABDOMINAL PAIN LOWER (Pain in lower abdomen periodically). At the time of the report, EAR PAIN (pain behind ear), CHEST PAIN (burning of her chest (like a sunburn)), PERIPHERAL COLDNESS (colder skin), TEARFULNESS (tearful), ANXIETY (anxiety), DEPRESSION (more depressed than usual) and ABDOMINAL PAIN LOWER (Pain in lower abdomen periodically) outcome was unknown.            No concomitant medication were provided.  No treatment medication were provided.  Action taken in response to mRNA-1273 was considered to be not applicable.   This case was linked to MOD-2021-058166 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Slight soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Slight soreness) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0211L20A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Slight soreness). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PAIN (Slight soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other relevant concomitant medication included statin.   This case was linked to -MODERNATX, INC.-MOD-2021-066954 (E2B Linked Report).; Sender's Comments:  -MODERNATX, INC.-MOD-2021-066954:2nd dose
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: Vaccine administered after temperature excursion; This spontaneous case was reported by a health care professional and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered after temperature excursion) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered after temperature excursion). On 02-Apr-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Vaccine administered after temperature excursion) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Tinnitus
Clinical narrative: Ringing in the ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in the ears) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) and PREDNISONE for an unknown indication.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Dec-2020, the patient experienced TINNITUS (Ringing in the ears). The patient was treated with PREDNISONE at an unspecified dose and frequency and MOMETASONE FUROATE (FLONASE [MOMETASONE FUROATE]) at an unspecified dose and frequency. At the time of the report, TINNITUS (Ringing in the ears) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: unknown (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Additional document received on 25-JUN-2021: Contain non-significant information. No new information.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Arthralgia, Feeling of body temperature change, Hyperhidrosis, Illness
Clinical narrative: Could not get out of bed; Hot and cold feeling; Sweating; Fever; Swollen Lymph nodes Armpit; Joint pain; Stomach pain; This spontaneous case was reported by an other health care professional and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (Hot and cold feeling), HYPERHIDROSIS (Sweating), PYREXIA (Fever), LYMPHADENOPATHY (Swollen Lymph nodes Armpit) and ARTHRALGIA (Joint pain) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hashimoto's disease.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (Hot and cold feeling), HYPERHIDROSIS (Sweating), PYREXIA (Fever), LYMPHADENOPATHY (Swollen Lymph nodes Armpit), ARTHRALGIA (Joint pain) and ABDOMINAL PAIN UPPER (Stomach pain). On 04-Feb-2021, the patient experienced ILLNESS (Could not get out of bed). On 07-Feb-2021, FEELING OF BODY TEMPERATURE CHANGE (Hot and cold feeling), HYPERHIDROSIS (Sweating), PYREXIA (Fever), LYMPHADENOPATHY (Swollen Lymph nodes Armpit), ARTHRALGIA (Joint pain), ABDOMINAL PAIN UPPER (Stomach pain) and ILLNESS (Could not get out of bed) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment information was reported.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pyrexia
Clinical narrative: Could not get out of bed; Hot and cold feeling; Sweating; Fever; Swollen Lymph nodes Armpit; Joint pain; Stomach pain; This spontaneous case was reported by an other health care professional and describes the occurrence of FEELING OF BODY TEMPERATURE CHANGE (Hot and cold feeling), HYPERHIDROSIS (Sweating), PYREXIA (Fever), LYMPHADENOPATHY (Swollen Lymph nodes Armpit) and ARTHRALGIA (Joint pain) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hashimoto's disease.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced FEELING OF BODY TEMPERATURE CHANGE (Hot and cold feeling), HYPERHIDROSIS (Sweating), PYREXIA (Fever), LYMPHADENOPATHY (Swollen Lymph nodes Armpit), ARTHRALGIA (Joint pain) and ABDOMINAL PAIN UPPER (Stomach pain). On 04-Feb-2021, the patient experienced ILLNESS (Could not get out of bed). On 07-Feb-2021, FEELING OF BODY TEMPERATURE CHANGE (Hot and cold feeling), HYPERHIDROSIS (Sweating), PYREXIA (Fever), LYMPHADENOPATHY (Swollen Lymph nodes Armpit), ARTHRALGIA (Joint pain), ABDOMINAL PAIN UPPER (Stomach pain) and ILLNESS (Could not get out of bed) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment information was reported.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Myalgia, Pain
Clinical narrative: Pain scale is 3/10 / spike up to 6-7/10 at times when he is asleep and rolls over; Left arm muscle pain/ seems to be getting worse; pain on injection site radiates down to his elbow; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain scale is 3/10 / spike up to 6-7/10 at times when he is asleep and rolls over), MYALGIA (Left arm muscle pain/ seems to be getting worse) and INJECTION SITE PAIN (pain on injection site radiates down to his elbow) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 0211L20A) for COVID-19 vaccination.     Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Pain scale is 3/10 / spike up to 6-7/10 at times when he is asleep and rolls over), MYALGIA (Left arm muscle pain/ seems to be getting worse) and INJECTION SITE PAIN (pain on injection site radiates down to his elbow). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PAIN (Pain scale is 3/10 / spike up to 6-7/10 at times when he is asleep and rolls over), MYALGIA (Left arm muscle pain/ seems to be getting worse) and INJECTION SITE PAIN (pain on injection site radiates down to his elbow) outcome was unknown.            Other relevant concomitant medication included statin.   This case was linked to US-MODERNATX, INC.-MOD-2021-066932 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-066932:1st dose
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Ear congestion, SARS-CoV-2 test, Tinnitus
Clinical narrative: Middle Ear Congestion; ringing in right ear; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EAR CONGESTION (Middle Ear Congestion) and TINNITUS (ringing in right ear) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy. Concomitant products included FLUTICASONE PROPIONATE (FLONASE ALLERGY RELIEF) and PREDNISONE for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Dec-2020, the patient experienced TINNITUS (ringing in right ear). On an unknown date, the patient experienced EAR CONGESTION (Middle Ear Congestion). At the time of the report, EAR CONGESTION (Middle Ear Congestion) outcome was unknown and TINNITUS (ringing in right ear) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient had negative for past history of COVID-19 . Patient diagnosed with middle ear congestion.   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Patient demographics is updated.Medical History is updated. Event list is updated.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Musculoskeletal stiffness, Pyrexia, Spinal pain
Clinical narrative: Pain in spine; Stiffness in neck and shoulder; Have a red circle in my arm; Ran very high fever next day and for two days; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 29-Mar-2021 and was forwarded to Moderna on 30-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SPINAL PAIN (Pain in spine), MUSCULOSKELETAL STIFFNESS (Stiffness in neck and shoulder), ERYTHEMA (Have a red circle in my arm) and PYREXIA (Ran very high fever next day and for two days) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 038A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SPINAL PAIN (Pain in spine), MUSCULOSKELETAL STIFFNESS (Stiffness in neck and shoulder), ERYTHEMA (Have a red circle in my arm) and PYREXIA (Ran very high fever next day and for two days). At the time of the report, SPINAL PAIN (Pain in spine), MUSCULOSKELETAL STIFFNESS (Stiffness in neck and shoulder), ERYTHEMA (Have a red circle in my arm) and PYREXIA (Ran very high fever next day and for two days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-061143 (Patient Link).
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pruritus, Rash pustular
Clinical narrative: Arm started itching; breaking out in pustules; little red marks; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Arm started itching), RASH PUSTULAR (breaking out in pustules) and ERYTHEMA (little red marks) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure high and Cholesterol.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Arm started itching), RASH PUSTULAR (breaking out in pustules) and ERYTHEMA (little red marks). At the time of the report, PRURITUS (Arm started itching), RASH PUSTULAR (breaking out in pustules) and ERYTHEMA (little red marks) outcome was unknown.            Concomitant medication includes high blood pressure and cholesterol medication. No treatment medication details was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-064268 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-064268:First dose
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Epistaxis, Haemoptysis, Headache, Migraine
Clinical narrative: Body hurts; Nose bleed upon blowing; Coughing up blood; Body pain that hurts worse; Migraine; Dizziness; Fever of 101.8 degrees fahrenheit; Bad headache; Arm started to hurt pretty bad, 10 minutes after shot; Pain traveled to neck and head; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm started to hurt pretty bad, 10 minutes after shot), NECK PAIN (Pain traveled to neck and head), PAIN (Body hurts), EPISTAXIS (Nose bleed upon blowing) and HAEMOPTYSIS (Coughing up blood) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sulfonamide allergy. Concurrent medical conditions included Bee sting hypersensitivity.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm started to hurt pretty bad, 10 minutes after shot), NECK PAIN (Pain traveled to neck and head), PAIN (Body pain that hurts worse), MIGRAINE (Migraine), DIZZINESS (Dizziness), PYREXIA (Fever of 101.8 degrees fahrenheit) and HEADACHE (Bad headache). On 31-Mar-2021, the patient experienced PAIN (Body hurts), EPISTAXIS (Nose bleed upon blowing) and HAEMOPTYSIS (Coughing up blood). At the time of the report, PAIN IN EXTREMITY (Arm started to hurt pretty bad, 10 minutes after shot), NECK PAIN (Pain traveled to neck and head), PAIN (Body hurts), EPISTAXIS (Nose bleed upon blowing), HAEMOPTYSIS (Coughing up blood), PAIN (Body pain that hurts worse), MIGRAINE (Migraine), DIZZINESS (Dizziness), PYREXIA (Fever of 101.8 degrees fahrenheit) and HEADACHE (Bad headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment products-Ibuprofen and Excedrin
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain, Pain in extremity, Pyrexia
Clinical narrative: Body hurts; Nose bleed upon blowing; Coughing up blood; Body pain that hurts worse; Migraine; Dizziness; Fever of 101.8 degrees fahrenheit; Bad headache; Arm started to hurt pretty bad, 10 minutes after shot; Pain traveled to neck and head; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm started to hurt pretty bad, 10 minutes after shot), NECK PAIN (Pain traveled to neck and head), PAIN (Body hurts), EPISTAXIS (Nose bleed upon blowing) and HAEMOPTYSIS (Coughing up blood) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 020B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Sulfonamide allergy. Concurrent medical conditions included Bee sting hypersensitivity.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm started to hurt pretty bad, 10 minutes after shot), NECK PAIN (Pain traveled to neck and head), PAIN (Body pain that hurts worse), MIGRAINE (Migraine), DIZZINESS (Dizziness), PYREXIA (Fever of 101.8 degrees fahrenheit) and HEADACHE (Bad headache). On 31-Mar-2021, the patient experienced PAIN (Body hurts), EPISTAXIS (Nose bleed upon blowing) and HAEMOPTYSIS (Coughing up blood). At the time of the report, PAIN IN EXTREMITY (Arm started to hurt pretty bad, 10 minutes after shot), NECK PAIN (Pain traveled to neck and head), PAIN (Body hurts), EPISTAXIS (Nose bleed upon blowing), HAEMOPTYSIS (Coughing up blood), PAIN (Body pain that hurts worse), MIGRAINE (Migraine), DIZZINESS (Dizziness), PYREXIA (Fever of 101.8 degrees fahrenheit) and HEADACHE (Bad headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment products-Ibuprofen and Excedrin
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthropathy
Clinical narrative: This spontaneous case reported by a consumer (subsequently medically confirmed), describes the occurrence of arthropathy (knee problem) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19  vaccine) for COVID-19 immunization. No medical history reported. On Feb 24, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 31, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced arthropathy (knee problem). The patient treated with ibuprofen for unspecified disorder of knee joint, at a dose of 1 dosage form. At the time of the report, arthropathy (knee problem) outcome: unknown/not provided. For mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; dosing remained unchanged. No concomitant medication reported. Action taken with mRNA-1273 in response to the drug: N/A.
Sex: U
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: Got Ill; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS. At the time of the report, ILLNESS outcome was unknown.            No concomitant medications were reported.   Treatment information was not reported.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: arm was sore for several; tired for the rest of the day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was sore for several) and FATIGUE (tired for the rest of the day) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm was sore for several) and FATIGUE (tired for the rest of the day). At the time of the report, PAIN IN EXTREMITY (arm was sore for several) and FATIGUE (tired for the rest of the day) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Action taken with mRNA-1273 in response to the drug was no change. No concomitant medication information was provided. No treatment medication information was provided.    This case was linked to MOD-2021-064419 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Chills, Illness, Pyrexia
Clinical narrative: Sick for a day and a half; Fever; Rigors in her legs; This spontaneous case was reported by a non-health professional and describes the occurrence of ILLNESS (Sick for a day and a half), PYREXIA (Fever) and CHILLS (Rigors in her legs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick for a day and a half), PYREXIA (Fever) and CHILLS (Rigors in her legs). At the time of the report, ILLNESS (Sick for a day and a half), PYREXIA (Fever) and CHILLS (Rigors in her legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's relevant concomitant medications weren't reported Treatment information was not provided
Sex: U
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test negative
Clinical narrative: negative serological antibody test results after having the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (negative serological antibody test results after having the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (negative serological antibody test results after having the vaccine). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (negative serological antibody test results after having the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was reported.   This case was linked to MOD-2021-066059, MOD-2021-066059 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Follow up information was received and contain no new information
Age: 16.0
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 16 year old twins received Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old twins received Moderna vaccine) in a 16-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old twins received Moderna vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old twins received Moderna vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-064213 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-064213:case for 1st of of twin
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash after taking it; This spontaneous case was reported by an other health care professional and describes the occurrence of RASH (rash after taking it) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Drug allergy (Dilantin).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash after taking it). At the time of the report, RASH (rash after taking it) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information for the event was provided.
Sex: U
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: First dose Moderna and Second dose Pfizer; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (First dose Moderna and Second dose Pfizer) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (First dose Moderna and Second dose Pfizer). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (First dose Moderna and Second dose Pfizer) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient's relevant concomitant medications weren't reported Treatment information was not provided
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: fever; chills; This spontaneous case was reported by a non-health professional and describes the occurrence of PYREXIA (fever) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever) and CHILLS (chills). At the time of the report, PYREXIA (fever) and CHILLS (chills) outcome was unknown.            The patient's concomitant medications weren't reported Treatment information was not provided
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: arm rash, another bad rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH (arm rash, another bad rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (arm rash, another bad rash). At the time of the report, RASH (arm rash, another bad rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  No treatment information provided.   This case was linked to MOD-2021-067091 (Patient Link).   Reporter did not allow further contact